Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?
Wendling
Daniel
D
Di Martino
Vincent
V
Herbein
Georges
G
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001688:Biological Products / Q000009:adverse effects*; D002908:Chronic Disease; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000821:virology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology; D014777:Virus Diseases / Q000188:drug therapy / Q000276:immunology*
D018501:Antirheumatic Agents; D001688:Biological Products; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha